Company / CapEx per Share
Dianthus Therapeutics, Inc. /DE/ CapEx per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2024
5-year range
$0.01 / $0.16
FY2020-FY2024
Trend
-65.2%
vs FY2023
Sector context
#131 of 192
Health Care
What the data says
At $0.01, Dianthus Therapeutics, Inc. /DE/'s capex per share ranks #131 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 9 years, ranging from $0.01 in FY2024 to $3.26 in FY2018.
Based on SEC 10-K filings.
0.01 in FY2024 with a 5-year CAGR of -39.5%.
Declined from $0.16 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -31.4%
- 5-Year CAGR
- -39.5%
- 10-Year CAGR
- -
Sector benchmark
#131 of 192 in Health CareTop 68% of 192This company $0.01 Sector average $2.46
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2024, capex per share decreased 65.2% year-over-year.
- Ranks #131 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.01 | -65.2% |
| FY2023 | $0.02 | -86.6% |
| FY2022 | $0.16 | +591.2% |
| FY2021 | $0.02 | +152.6% |
| FY2020 | $0.01 | -90.1% |
| FY2019 | $0.09 | -97.2% |
| FY2018 | $3.26 | +175.5% |
| FY2017 | $1.18 | +27.3% |
| FY2016 | $0.93 | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026